Role of stearoyl-CoA desaturase in human metabolic disease

Harini Sampath, James M. Ntambi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Stearoyl-CoA desaturase (SCD) is a highly conserved Δ-9 desaturase that converts saturated fatty acids into monounsaturated fatty acids. Mice lacking the Scd1 gene are characterized by decreased adiposity and increased lipid oxidation and insulin sensitivity in liver and skeletal muscle. Two isoforms of SCD have also been identified in humans, and there appears to be an association between SCD expression and adiposity. This review will provide a brief update of recent progress in understanding the role of SCD in mediating the progression of disease in human populations, with a special emphasis on metabolic disease.

Original languageEnglish (US)
Pages (from-to)163-173
Number of pages11
JournalFuture Lipidology
Volume3
Issue number2
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Stearoyl-CoA Desaturase
Metabolic Diseases
Adiposity
Monounsaturated Fatty Acids
Liver
Muscle
Disease Progression
Insulin Resistance
Protein Isoforms
Skeletal Muscle
Fatty Acids
Genes
Association reactions
Insulin
Lipids
Oxidation
Population

Keywords

  • Desaturation ratio
  • Hypertriglyceridemia
  • Insulin sensitivity
  • Lipid oxidation
  • Lipogenesis
  • Metabolic syndrome
  • Stearoyl CoA desaturase

ASJC Scopus subject areas

  • Biochemistry

Cite this

Role of stearoyl-CoA desaturase in human metabolic disease. / Sampath, Harini; Ntambi, James M.

In: Future Lipidology, Vol. 3, No. 2, 04.2008, p. 163-173.

Research output: Contribution to journalArticle

Sampath, Harini ; Ntambi, James M. / Role of stearoyl-CoA desaturase in human metabolic disease. In: Future Lipidology. 2008 ; Vol. 3, No. 2. pp. 163-173.
@article{754692de2b114de9ad70fa407e073bff,
title = "Role of stearoyl-CoA desaturase in human metabolic disease",
abstract = "Stearoyl-CoA desaturase (SCD) is a highly conserved Δ-9 desaturase that converts saturated fatty acids into monounsaturated fatty acids. Mice lacking the Scd1 gene are characterized by decreased adiposity and increased lipid oxidation and insulin sensitivity in liver and skeletal muscle. Two isoforms of SCD have also been identified in humans, and there appears to be an association between SCD expression and adiposity. This review will provide a brief update of recent progress in understanding the role of SCD in mediating the progression of disease in human populations, with a special emphasis on metabolic disease.",
keywords = "Desaturation ratio, Hypertriglyceridemia, Insulin sensitivity, Lipid oxidation, Lipogenesis, Metabolic syndrome, Stearoyl CoA desaturase",
author = "Harini Sampath and Ntambi, {James M.}",
year = "2008",
month = "4",
doi = "10.2217/17460875.3.2.163",
language = "English (US)",
volume = "3",
pages = "163--173",
journal = "Clinical Lipidology",
issn = "1746-0875",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Role of stearoyl-CoA desaturase in human metabolic disease

AU - Sampath, Harini

AU - Ntambi, James M.

PY - 2008/4

Y1 - 2008/4

N2 - Stearoyl-CoA desaturase (SCD) is a highly conserved Δ-9 desaturase that converts saturated fatty acids into monounsaturated fatty acids. Mice lacking the Scd1 gene are characterized by decreased adiposity and increased lipid oxidation and insulin sensitivity in liver and skeletal muscle. Two isoforms of SCD have also been identified in humans, and there appears to be an association between SCD expression and adiposity. This review will provide a brief update of recent progress in understanding the role of SCD in mediating the progression of disease in human populations, with a special emphasis on metabolic disease.

AB - Stearoyl-CoA desaturase (SCD) is a highly conserved Δ-9 desaturase that converts saturated fatty acids into monounsaturated fatty acids. Mice lacking the Scd1 gene are characterized by decreased adiposity and increased lipid oxidation and insulin sensitivity in liver and skeletal muscle. Two isoforms of SCD have also been identified in humans, and there appears to be an association between SCD expression and adiposity. This review will provide a brief update of recent progress in understanding the role of SCD in mediating the progression of disease in human populations, with a special emphasis on metabolic disease.

KW - Desaturation ratio

KW - Hypertriglyceridemia

KW - Insulin sensitivity

KW - Lipid oxidation

KW - Lipogenesis

KW - Metabolic syndrome

KW - Stearoyl CoA desaturase

UR - http://www.scopus.com/inward/record.url?scp=47249089071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249089071&partnerID=8YFLogxK

U2 - 10.2217/17460875.3.2.163

DO - 10.2217/17460875.3.2.163

M3 - Article

AN - SCOPUS:47249089071

VL - 3

SP - 163

EP - 173

JO - Clinical Lipidology

JF - Clinical Lipidology

SN - 1746-0875

IS - 2

ER -